Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Study of Hydralazine and Valproic Acid in Combination With Neoadjuvant Cytotoxic Chemotherapy in Stage IIB and IIIA Breast Carcinoma

NCT00395655 is registered in ClinicalTrials.gov with National Institute of Cancerología as lead sponsor.

NCT NCT00395655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00395655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Study of Hydralazine and Valproic Acid in Combination With Neoadjuvant Cytotoxic Chemotherapy in Stage IIB and IIIA Breast Carcinoma
Lead sponsor
National Institute of Cancerología
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2005
Completion date
August 31, 2006
Enrollment
43
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced breast cancer